Sponsor pipeline

Shenzhen Salubris Pharmaceuticals Co., Ltd. clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

First posted	Trial	Phase	Status
2026-10-19	NCT07879755 An Extension Trial of GW 906 in Participants With Essential Hypertension		Recruiting
2026-09-23	NCT07835971 A Study to Evaluate Efficacy and Safety of GW906 in Patients With Essential Hypertension	Phase 2	Active, Not Recruiting
2026-09-23	NCT07835984 A Study to Evaluate Efficacy and Safety of GW906 Used as Add-on Therapy in Patients With…	Phase 2	Not Yet Recruiting

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Get alerts when Shenzhen Salubris Pharmaceuticals Co., Ltd.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.